155 related articles for article (PubMed ID: 34055197)
1. Chinese Herbal Prescription Fu-Zheng-Qu-Xie Prevents Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration.
Zhang S; Chen W; Wang Y; Wu J; Xu L; Yu Y; Tian J; Xu R; Fang Z; Jiang L; Luo Y; Li Y
Oxid Med Cell Longev; 2021; 2021():6673828. PubMed ID: 34055197
[TBL] [Abstract][Full Text] [Related]
2. Revealing the Preventable Effects of Fu-Zheng-Qu-Xie Decoction against Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma Based on Network Pharmacology Coupled with Metabolomics Analysis.
Zhang Y; Ma K; Jiang L; Xu L; Luo Y; Wu J; Li Y
ACS Omega; 2023 Oct; 8(39):35555-35570. PubMed ID: 37810735
[TBL] [Abstract][Full Text] [Related]
3. The Tian-Men-Dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1β-mediated signalling in lung cancer.
Su L; Zhang F; Liu MX; Li H; Li Q; Zhu YZ; Hou YF; Chen X; Wang XY; Qian CM; Yao C; Wang LX; Jiao XN; Zhu XD; Xu ZH; Zou CP
J Ethnopharmacol; 2023 Sep; 313():116491. PubMed ID: 37072091
[TBL] [Abstract][Full Text] [Related]
4. Shuangshen granules attenuate lung metastasis by modulating bone marrow differentiation through mTOR signalling inhibition.
Wei H; Guo C; Zhu R; Zhang C; Han N; Liu R; Hua B; Li Y; Lin H; Yu J
J Ethnopharmacol; 2021 Dec; 281():113305. PubMed ID: 32890710
[TBL] [Abstract][Full Text] [Related]
5. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.
Pan T; Zhang F; Li F; Gao X; Li Z; Li X; Ren X
Oncol Rep; 2020 Sep; 44(3):1049-1063. PubMed ID: 32705271
[TBL] [Abstract][Full Text] [Related]
6. Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis.
Yin Y; Wang Y; Wang C; Zhang Y; Qi A; Song J; Xu L; Yang W; Jiao L
J Ethnopharmacol; 2024 May; 326():117984. PubMed ID: 38428661
[TBL] [Abstract][Full Text] [Related]
7. Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway.
Li S; Zhou G; Liu W; Ye J; Yuan F; Zhang Z
Oncol Res; 2021 Sep; 28(7):685-700. PubMed ID: 32886059
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients.
Liu J; Hao J; Niu Y; Wu X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2079-2092. PubMed ID: 33797608
[TBL] [Abstract][Full Text] [Related]
9. [Effect of fu-zheng qu-xie on gastric disease infected with Campylobacter pyloridis].
Fang JY
Zhong Xi Yi Jie He Za Zhi; 1991 Mar; 11(3):150-2, 133. PubMed ID: 2065393
[TBL] [Abstract][Full Text] [Related]
10. Jinfukang inhibits lung cancer metastasis by regulating T cell receptors.
Luo B; Wang P; Tian J; Chu X; Lu X; Yang Y; Zhou Y; Li Y; Que Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116885. PubMed ID: 37422099
[TBL] [Abstract][Full Text] [Related]
11. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
[TBL] [Abstract][Full Text] [Related]
12. Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor Cells.
Wang Y; Sun N; Luo Y; Fang Z; Fang Y; Tian J; Yu Y; Wu J; Li Y
Evid Based Complement Alternat Med; 2021; 2021():6624461. PubMed ID: 33986819
[TBL] [Abstract][Full Text] [Related]
13. Reductions in myeloid-derived suppressor cells and lung metastases using AZD4547 treatment of a metastatic murine breast tumor model.
Liu L; Ye TH; Han YP; Song H; Zhang YK; Xia Y; Wang NY; Xiong Y; Song XJ; Zhu YX; Li de L; Zeng J; Ran K; Peng CT; Wei YQ; Yu LT
Cell Physiol Biochem; 2014; 33(3):633-45. PubMed ID: 24642893
[TBL] [Abstract][Full Text] [Related]
14. The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.
Lee JW; Zhang Y; Eoh KJ; Sharma R; Sanmamed MF; Wu J; Choi J; Park HS; Iwasaki A; Kaftan E; Chen L; Papadimitrakopoulou V; Herbst RS; Koo JS
J Thorac Oncol; 2019 Jun; 14(6):1046-1060. PubMed ID: 30771521
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence.
Liu D; Lin S; Li Y; Zhou T; Hu K; Li Q
Drug Des Devel Ther; 2022; 16():375-395. PubMed ID: 35210754
[TBL] [Abstract][Full Text] [Related]
18. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
19. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract][Full Text] [Related]
20. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
